499
Views
2
CrossRef citations to date
0
Altmetric
Invited Reviews

Endogenous Endophthalmitis - A Major Review

, MBBS, , MS, , MSORCID Icon, , MSORCID Icon, , MDORCID Icon, , MDORCID Icon, , MSORCID Icon, , MDORCID Icon, , MMed & , MS show all
Pages 1362-1385 | Received 17 Apr 2022, Accepted 15 Sep 2022, Published online: 28 Oct 2022

References

  • Romero CF, Rai MK, Lowder CY, Adal KA. Endogenous endophthalmitis: case report and brief review. Am Fam Physician. 1999;60:510.
  • Sadiq MA, Hassan M, Agarwal A, et al. Endogenous endophthalmitis: diagnosis, management, and prognosis. J Ophthalmic Inflamm Infect. 2015;5(1):1–11. doi:10.1186/s12348-015-0063-y.
  • Michael NDB, Gunaseelan S, Jaffar TNT, Noordin Z, Hussein A. Endogenous endophthalmitis: a five-year review of cases at the Raja Perempuan Zainab II Hospital, Kelantan, Malaysia. Cureus. 2018;10(7).
  • Connell PP, O’neill EC, Fabinyi D, et al. Endogenous endophthalmitis: 10-year experience at a tertiary referral centre. Eye. 2011;25(1):66–72. doi:10.1038/eye.2010.145.
  • Zhy W, Chan RPS, Luk FOJ, et al. Review of clinical features, microbiological spectrum, and treatment outcomes of endogenous endophthalmitis over an 8-year period. J Ophthalmol. 2012;2012.
  • Vaziri K, Pershing S, Albini TA, Moshfeghi DM, Moshfeghi AA. Risk factors predictive of endogenous endophthalmitis among hospitalized patients with hematogenous infections in the United States. Am J Ophthalmol. 2015;159(3):498–504. doi:10.1016/j.ajo.2014.11.032.
  • Wang K, Krishnan G, Pershing S. Ophthalmology consultation to detect endogenous endophthalmitis: clinical characteristics in consulted versus diagnosed cases among at-risk inpatients. Ophthalmic Surg Lasers Imaging Retina. 2020;51(3):159–A3. doi:10.3928/23258160-20200228-05.
  • Shah M, Relhan N, Kuriyan AE, et al. Endophthalmitis caused by nontuberculous mycobacterium: clinical features, antimicrobial susceptibilities, and treatment outcomes. Am J Ophthalmol. 2016;168:150–156. doi:10.1016/j.ajo.2016.03.035.
  • Yang G, Huang X, Jiang S, Xu Z. Endogenous endophthalmitis caused by Klebsiella pneumoniae: a ten-year retrospective study in Western China. Ophthalmic Res. 2020;63(5):507–516. doi:10.1159/000505928.
  • Regan KA, Radhakrishnan NS, Hammer JD, Wilson BD, Gadkowski LB, Iyer SSR. Endogenous endophthalmitis: yield of the diagnostic evaluation. BMC Ophthalmol. 2020;20(1):1–7. doi:10.1186/s12886-020-01418-9.
  • Hsieh MC, Chen SN, Cheng CY, et al. Clinicomicrobiological profile, visual outcome and mortality of culture-proven endogenous endophthalmitis in Taiwan. Sci Rep. 2020;10(1):1–8. doi:10.1038/s41598-020-69251-0.
  • Pillai GS, Remadevi KK, Anilkumar V, Radhakrishnan N, Rasheed R, Ravindran GC. Clinical profile and outcome of endogenous endophthalmitis at a quaternary referral centre in south India. Indian J Ophthalmol. 2020;68(5):827. doi:10.4103/ijo.IJO_948_19.
  • Bhurayanontachai P, Klongthanakit P. A 14-year retrospective analysis of endogenous endophthalmitis in a tertiary referral Center of Southern Thailand. J Ophthalmol. 2020;2020:1–8. doi:10.1155/2020/6689081.
  • Chung KS, Kim YK, Song YG, et al. Clinical review of endogenous endophthalmitis in Korea: a 14-year review of culture positive cases of two large hospitals. Yonsei Med J. 2011;52(4):630–634. doi:10.3349/ymj.2011.52.4.630.
  • Muda R, Vayavari V, Subbiah D, Ishak H, Adnan A, Mohamed SO. Endogenous endophthalmitis: a 9-year retrospective study at a tertiary referral hospital in Malaysia. J Ophthalmic Inflamm Infect. 2018;8(1):1–17. doi:10.1186/s12348-018-0158-3.
  • Lourthai P, Choopong P, Dhirachaikulpanich D, et al. Visual outcome of endogenous endophthalmitis in Thailand. Sci Rep. 2021;11(1):1–5. doi:10.1038/s41598-021-93730-7.
  • Maitray A, Rishi E, Rishi P, et al. Endogenous endophthalmitis in children and adolescents: case series and literature review. Indian J Ophthalmol. 2019;67(6):795. doi:10.4103/ijo.IJO_710_18.
  • Chien KH, Huang KH, Chung CH, et al. The impact of diabetes mellitus medication on the incidence of endogenous endophthalmitis. PLoS One. 2020;15(1):e0227442. doi:10.1371/journal.pone.0227442.
  • Narang S, Gupta A, Gupta V, et al. Fungal endophthalmitis following cataract surgery: clinical presentation, microbiological spectrum, and outcome. Am J Ophthalmol. 2001;132(5):609–617. doi:10.1016/S0002-9394(01)01180-1.
  • Yonekawa Y, Chan RVP, Reddy AK, Pieroni CG, Lee TC, Lee S. Early intravitreal treatment of endogenous bacterial endophthalmitis. Clin Exp Ophthalmol. 2011;39(8):771–778. doi:10.1111/j.1442-9071.2011.02545.x.
  • Yang CS, Tsai HY, Sung CS, Lin KH, Lee FL, Hsu WM. Endogenous Klebsiella endophthalmitis associated with pyogenic liver abscess. Ophthalmology. 2007;114(5):876–880. doi:10.1016/j.ophtha.2006.12.035.
  • Balaskas K, Potamitou D. Endogenous endophthalmitis secondary to bacterial meningitis from Neisseria Meningitidis: a case report and review of the literature. Cases J. 2009;2(1):1–4. doi:10.1186/1757-1626-2-149.
  • Guillán EMP, Macía-Rodríguez C, Villafranca AG, Del Cm RM, Novo-Veleiro I. Menigococcal endophthalmitis: a rare cause of endogenous endophthalmitis. IDCases. 2020;22:e00997. doi:10.1016/j.idcr.2020.e00997.
  • Torii H, Miyata H, Sugisaka E, Ichikawa Y, Shinoda K, Inoue M. Bilateral endophthalmitis in a patient with bacterial meningitis caused by Streptococcus pneumoniae. Ophthalmologica. 2008;222(5):357–359. doi:10.1159/000149823.
  • Ang M, Jap A, Chee SP. Prognostic factors and outcomes in endogenous Klebsiella pneumoniae endophthalmitis. Am J Ophthalmol. 2011;151(2):338–344. doi:10.1016/j.ajo.2010.08.036.
  • Yoon YH, Lee SU, Sohn JH, Lee SE. Result of early vitrectomy for endogenousklebsiella pneumoniaeendophthalmitis. Retina. 2003;23(3):366–370. doi:10.1097/00006982-200306000-00013.
  • Chung CY, Wong ES, Liu CCH, Wong MOM, Li KKW. Clinical features and prognostic factors of Klebsiella endophthalmitis—10-year experience in an endemic region. Eye. 2017;31(11):1569–1575. doi:10.1038/eye.2017.92.
  • Celiker H, Kazokoglu H. The role of pars plana vitrectomy in the management of fungal endogenous endophthalmitis. Eur J Ophthalmol. 2020;30(1):88–93. doi:10.1177/1120672118815105.
  • Dave VP, Pathengay A, Panchal B, et al. Clinical presentations, microbiology and management outcomes of culture-proven endogenous endophthalmitis in India. Indian J Ophthalmol. 2020;68(5):834. doi:10.4103/ijo.IJO_1091_19.
  • Silpa-Archa S, Ponwong A, Preble JM, Foster CS. Culture-positive endogenous endophthalmitis: an eleven-year retrospective study in the central region of Thailand. Ocul Immunol Inflamm. 2018;26(4):533–542. doi:10.1080/09273948.2017.1355469.
  • Mir TA, Papudesu C, Fang W, Hinkle DM. Incidence of drug use–related endogenous endophthalmitis hospitalizations in the United States, 2003 to 2016. JAMA Ophthalmol. 2021;139(1):18–26. doi:10.1001/jamaophthalmol.2020.4741.
  • Maling S, King C, Davies N. A British ophthalmological surveillance unit study on metastatic endogenous endophthalmitis. Eye. 2018;32(4):743–748. doi:10.1038/eye.2017.284.
  • Kim DY, Moon HI, Joe SG, Kim JG, Yoon YH, Lee JY. Recent clinical manifestation and prognosis of fungal endophthalmitis: a 7-year experience at a tertiary referral center in Korea. J Korean Med Sci. 2015;30(7):960–964. doi:10.3346/jkms.2015.30.7.960.
  • Wang SH, Lee JJ, Chen YJ, Kuo HK. Endogenous candida endophthalmitis in South Taiwan: a 10-year retrospective study. Taiwan J Ophthalmol. 2013;3(4):146–150. doi:10.1016/j.tjo.2013.10.002.
  • Patel SN, Rescigno RJ, Zarbin MA, Langer P, Bhagat N. Endogenous endophthalmitis associated with intravenous drug abuse. Retina. 2014;34(7):1460–1465. doi:10.1097/IAE.0000000000000084.
  • Modjtahedi BS, Finn AV, Papakostas TD, Durand M, Husain D, Eliott D. Intravenous drug use–associated endophthalmitis. Ophthalmol Retin. 2017;1(3):192–199. doi:10.1016/j.oret.2016.10.013.
  • Tirpack AR, Duker JS, Baumal CR. An outbreak of endogenous fungal endophthalmitis among intravenous drug abusers in New England. JAMA Ophthalmol. 2017;135(6):534–540. doi:10.1001/jamaophthalmol.2017.0650.
  • Dogra M, Akella M, Dogra MR, Gupta A. Presumably contaminated intravenous infusion-induced Aspergillus terreus endogenous endophthalmitis presenting with posterior hypopyon. Indian J Ophthalmol. 2018;66(4):593. doi:10.4103/ijo.IJO_695_17.
  • Viswanathaiah S, Babu M, Manjunatha M. Endogenous endophthalmitis caused by Aspergillus flavus in an immunocompetent individual–A rare case with review of literature. J Acad Clin Microbiol. 2019;21(1):34. doi:10.4103/jacm.jacm_8_18.
  • Karkhur S, Afridi R, Menia N, et al. Posterior hypopyon in fungal endogenous endophthalmitis secondary to presumably contaminated dextrose infusion. Am J Ophthalmol Case Reports. 2020;18:100681. doi:10.1016/j.ajoc.2020.100681.
  • Wong JS, Chan TK, Lee HM, Chee SP. Endogenous bacterial endophthalmitis: an east Asian experience and a reappraisal of a severe ocular affliction. Ophthalmology. 2000;107(8):1483–1491. doi:10.1016/S0161-6420(00)00216-5.
  • Chen YH, Li YH, Lin JY, et al. Prognostic factors and visual outcomes of pyogenic liver abscess-related endogenous Klebsiella pneumoniae endophthalmitis: a 20-year retrospective review. Sci Rep. 2019;9(1):1–8. doi:10.1038/s41598-018-37186-2.
  • Siu LK, Yeh KM, Lin JC, Fung CP, Chang FY. Klebsiella pneumoniae liver abscess: a new invasive syndrome. Lancet Infect Dis. 2012;12(11):881–887. doi:10.1016/S1473-3099(12)70205-0.
  • Okada AA, Johnson RP, Liles WC, D’Amico DJ, Baker AS. Endogenous bacterial endophthalmitis: report of a ten-year retrospective study. Ophthalmology. 1994;101(5):832–838. doi:10.1016/S0161-6420(13)31255-X.
  • Callegan MC, Engelbert M, Parke DW, Jett BD, Gilmore MS. Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions. Clin Microbiol Rev. 2002;15(1):111–124. doi:10.1128/CMR.15.1.111-124.2002.
  • Agarwal M, Sachdeva M, Pal S, Shah H, Kumar RM, Banker A. Endogenous endophthalmitis a complication of COVID-19 pandemic: a case series. Ocul Immunol Inflamm. 2021;29(4):726–729. doi:10.1080/09273948.2021.1945111.
  • Bilgic A, Sudhalkar A, Gonzalez-Cortes JH, et al. Endogenous endophthalmitis in the setting of COVID-19 infection: a case series. Retina. 2021;41(8):1709–1714. doi:10.1097/IAE.0000000000003168.
  • Goyal M, Murthy SI, Annum S. Retinal manifestations in patients following COVID-19 infection: a consecutive case series. Indian J Ophthalmol. 2021;69(5):1275. doi:10.4103/ijo.IJO_403_21.
  • Shroff D, Narula R, Atri N, et al. Endogenous fungal endophthalmitis following intensive corticosteroid therapy in severe COVID-19 disease. Indian J Ophthalmol. 2021;69(7):1909. doi:10.4103/ijo.IJO_592_21.
  • Sahu ES, Lahoti K, Bhargava A, Subhedar V, Sahu A. Subretinal aspergillus abscess in post COVID-19 recovered patients–an emerging problem. Ocul Immunol Inflamm. 2021; Published online:1–7. doi:10.1080/09273948.2021.1993271.
  • Nayak S, Das T, Parameswarappa D, et al. Sight-threatening intraocular infection in patients with COVID-19 in India. Indian J Ophthalmol. 2021;69(12):3664. doi:10.4103/ijo.IJO_1474_21.
  • Krčméry V, Matejička F, Pichňová E, et al. Documented fungal infections after prophylaxis or therapy with wide spectrum antibiotics: relationship between certain fungal pathogens and particular antimicrobials? J Chemother. 1999;11(5):385–390. doi:10.1179/joc.1999.11.5.385.
  • Gutierrez D, Weinstock A, Antharam VC, et al. Antibiotic-induced gut metabolome and microbiome alterations increase the susceptibility to Candida albicans colonization in the gastrointestinal tract. FEMS Microbiol Ecol. 2020;96(1):fiz187. doi:10.1093/femsec/fiz187.
  • Rodrigues CF, Rodrigues ME, Henriques M. Candida sp. infections in patients with diabetes mellitus. J Clin Med. 2019;8(1):76. doi:10.3390/jcm8010076.
  • Yang L, Gou J, Gao J, et al. Immune characteristics of severe and critical COVID-19 patients. Signal Transduct Target Ther. 2020;5(1):1–3. doi:10.1038/s41392-019-0089-y.
  • Sridhar J, Flynn HW, Kuriyan AE, Miller D, Albini T. Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections. J Ophthalmic Inflamm Infect. 2013;3(1):1–6. doi:10.1186/1869-5760-3-60.
  • Lingappan A, Wykoff CC, Albini TA, et al. Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol. 2012;153(1):162–166. doi:10.1016/j.ajo.2011.06.020.
  • Lin CJ, Chen WL, Lin JM, Tien PT, Tsai YY. Endogenous endophthalmitis caused by Cryptococcus neoformans Var. Gattii mimicking choroidal tumor: from positron-emission tomography/computed tomography to histopathology. Indian J Ophthalmol. 2017;65(6):526. doi:10.4103/ijo.IJO_543_16.
  • Riddell Iv J, McNeil SA, Johnson TM, Bradley SF, Kazanjian PH, Kauffman CA. Endogenous Aspergillus endophthalmitis: report of 3 cases and review of the literature. Medicine (Baltimore). 2002;81(4):311–320. doi:10.1097/00005792-200207000-00007.
  • Zhang H, Liu Z. Endogenous endophthalmitis: a 10-year review of culture-positive cases in northern China. Ocul Immunol Inflamm. 2010;18(2):133–138. doi:10.3109/09273940903494717.
  • Ness T, Pelz K, Hansen LL. Endogenous endophthalmitis: microorganisms, disposition and prognosis. Acta Ophthalmol Scand. 2007;85(8):852–856. doi:10.1111/j.1600-0420.2007.00982.x.
  • Jackson TL, Eykyn SJ, Graham EM, Stanford MR. Endogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported cases. Surv Ophthalmol. 2003;48(4):403–423. doi:10.1016/S0039-6257(03)00054-7.
  • Cho H, Shin YU, Siegel NH, et al. Endogenous endophthalmitis in the American and Korean population: an 8-year retrospective study. Ocul Immunol Inflamm. 2018;26(4):496–503. doi:10.1080/09273948.2016.1195000.
  • Lohmann CP, Gabel VP, Heep M, Linde HJ, Reischl U. Listeria monocytogenes-induced endogenous endophthalmitis in an otherwise healthy individual: rapid PCR-diagnosis as the basis for effective treatment. Eur J Ophthalmol. 1999;9(1):53–57. doi:10.1177/112067219900900108.
  • Zhang X, Brodie FL, Postel EA, Seidelman JL. Endogenous methicillin-resistant Staphylococcus aureus (MRSA) endophthalmitis: a six-year series at a tertiary care center. Ocul Immunol Inflamm. 2021; Published online:1–5. doi:10.1080/09273948.2021.1906911.
  • Chew KL, Lin RTP, Teo JWP. Klebsiella pneumoniae in Singapore: hypervirulent infections and the carbapenemase threat. Front Cell Infect Microbiol. 2017;7:515. doi:10.3389/fcimb.2017.00515.
  • Antaki F, Javidi S, Touma S, Aubin MJ. Endogenous tuberculous endophthalmitis and panophthalmitis: a systematic review of case reports and case series. Clin Ophthalmol (Auckland, NZ). 2020;14:3075. doi:10.2147/OPTH.S265521.
  • Pinitpuwadol W, Tesavibul N, Boonsopon S, Sakiyalak D, Sarunket S, Choopong P. Nontuberculous mycobacterial endophthalmitis: case series and review of literature. BMC Infect Dis. 2020;20(1):1–11. doi:10.1186/s12879-020-05606-2.
  • Milman T, Trubnik V, Shah M, McCormick SA, Finger PT. Isolated Nocardia exalbida endogenous endophthalmitis. Ocul Immunol Inflamm. 2011;19(4):237–239. doi:10.3109/09273948.2011.563898.
  • Chaudhry IA, Shamsi FA, Al-Dhibi H, Khan AO. Pediatric endogenous bacterial endophthalmitis: case report and review of the literature. J Am Assoc Pediatr Ophthalmol Strabismus {JAAPOS}. 2006;10(5):491–493. doi:10.1016/j.jaapos.2006.06.005.
  • Papudesu C, Mir T, Fang W, Thompson J, Hinkle DM. Trends in infantile endogenous endophthalmitis hospitalizations in the United States: an analysis from 2007 through 2014 using the national inpatient sample. Ophthalmol Retin. 2020;4(11):1109–1117. doi:10.1016/j.oret.2020.04.025.
  • Al-Khersan H, Pirakitikulr N, Kalavar M, et al. Primary evisceration for neonatal endogenous endophthalmitis: a report of two cases. Am J Ophthalmol Case Reports. 2021;22:101081. doi:10.1016/j.ajoc.2021.101081.
  • Melo GB, Hofling-Lima AL, Bispo PJ, Pignatari AC. Real-time PCR for the diagnosis of bacterial endophthalmitis. Invest Ophthalmol Vis Sci. 2011;52:5609.
  • Odouard C, Ong D, Shah PR, et al. Rising trends of endogenous Klebsiella pneumoniae endophthalmitis in Australia. Clin Exp Ophthalmol. 2017;45(2):135–142. doi:10.1111/ceo.12827.
  • Rahman W, Hanson R, Westcott M. A rare case of peripartum endogenous bacterial endophthalmitis. Int Ophthalmol. 2011;31(2):113–115. doi:10.1007/s10792-010-9399-3.
  • Xu H, Fu B, Lu C, Xu L, Sun J. Successful treatment of endogenous endophthalmitis with extensive subretinal abscess: a case report. BMC Ophthalmol. 2018;18(1):1–7. doi:10.1186/s12886-018-0908-x.
  • Parke IIDW, Jones DB, Gentry LO. Endogenous endophthalmitis among patients with candidemia. Ophthalmology. 1982;89(7):789–796. doi:10.1016/S0161-6420(82)34722-3.
  • Nishida T, Ishida K, Niwa Y, Kawakami H, Mochizuki K, Ohkusu K. An eleven-year retrospective study of endogenous bacterial endophthalmitis. J Ophthalmol. 2015;2015:1–11. doi:10.1155/2015/261310.
  • Binder MI, Chua J, Kaiser PK, Procop GW, Isada CM. Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center. Medicine (Baltimore). 2003;82(2):97–105. doi:10.1097/00005792-200303000-00004.
  • Jackson TL, Paraskevopoulos T, Georgalas I. Systematic review of 342 cases of endogenous bacterial endophthalmitis. Surv Ophthalmol. 2014;59(6):627–635. doi:10.1016/j.survophthal.2014.06.002.
  • Mahendradas P, Sanjay S, Shettiagar A, et al. In vivo confocal microscopy features in post COVID19 fungal endophthalmitis in type 2 diabetes. Published online 2021.
  • Kabbara S, Kelkar N, Conway MD, Peyman GA. Endogenous endophthalmitis: etiology and treatment. Infect Eye Dis Recent Adv Diagnosis Treat. 2021; 125. Published online.
  • Rao NA, Hidayat AA. Endogenous mycotic endophthalmitis: variations in clinical and histopathologic changes in candidiasis compared with aspergillosis. Am J Ophthalmol. 2001;132(2):244–251. doi:10.1016/S0002-9394(01)00968-0.
  • Chhablani J. Fungal endophthalmitis. Expert Rev Anti Infect Ther. 2011;9(12):1191–1201. doi:10.1586/eri.11.139.
  • Oude Lashof AML, Rothova A, Sobel JD, et al. Ocular manifestations of candidemia. Clin Infect Dis. 2011;53(3):262–268. doi:10.1093/cid/cir355.
  • Durand ML. Bacterial and fungal endophthalmitis. Clin Microbiol Rev. 2017;30(3):597–613. doi:10.1128/CMR.00113-16.
  • Biju R, Sushil D, Georgy NK. Successful management of presumed Candida endogenous endophthalmitis with oral voriconazole. Indian J Ophthalmol. 2009;57(4):306. doi:10.4103/0301-4738.53058.
  • Singh SR, Bhattacharyya A, Dogra MR, Singh R, Dogra M. Endogenous endophthalmitis due to Staphylococcus aureus in a lactating woman. Indian J Ophthalmol. 2020;68(11):2595. doi:10.4103/ijo.IJO_740_20.
  • Tan N, Galvante PRE, Chee SP. Endogenous Serratia marcescens endophthalmitis: an atypical presentation. Eye. 2014;28(1):108–109. doi:10.1038/eye.2013.237.
  • Maresova K, Poláchová J, Babkova B, Rehak J. Ultrasound findings in endophthalmitis. Ces a Slov Oftalmol Cas Ces Oftalmol Spol a Slov Oftalmol Spol. 2004;60:290–295.
  • Invernizzi A, Symes R, Miserocchi E, et al. Spectral domain optical coherence tomography findings in endogenous candida endophthalmitis and their clinical relevance. Retina. 2018;38(5):1011–1018. doi:10.1097/IAE.0000000000001630.
  • Zhuang H, Ding X, Gao F, et al. Optical coherence tomography features of retinal lesions in Chinese patients with endogenous Candida endophthalmitis. BMC Ophthalmol. 2020;20(1):1–8. doi:10.1186/s12886-020-01337-9.
  • Sjoholm-Gomez de Liano C, Soberon-Ventura VF, Salcedo-Villanueva G, et al. Sensitivity, specificity and predictive values of anterior chamber tap in cases of bacterial endophthalmitis. Eye Vis. 2017;4(1):1–6. doi:10.1186/s40662-017-0083-9.
  • Ma WJ, Zhang H, Zhao SZ. Laboratory diagnosis of infectious endophthalmitis. Int J Ophthalmol. 2011;4(1):100. doi:10.3980/j.2222-3959.2011.01.23.
  • Greenwald MJ, Wohl LG, Sell CH. Metastatic bacterial endophthalmitis: a contemporary reappraisal. Surv Ophthalmol. 1986;31(2):81–101. doi:10.1016/0039-6257(86)90076-7.
  • Okhravi N, Adamson P, Carroll N, et al. PCR-based evidence of bacterial involvement in eyes with suspected intraocular infection. Invest Ophthalmol Vis Sci. 2000;41(11):3474–3479.
  • Danielescu C, Anton N, Stanca HT, Munteanu M. Endogenous endophthalmitis: a review of case series published between 2011 and 2020. J Ophthalmol. 2020;2020. doi:10.1155/2020/8869590.
  • Tanaka T, de A FBF, de Oliveira LMS, et al. Diagnostic value of pediatric blood culture bottles for acute postoperative endophthalmitis. Clinics. 2019;74:e837. doi:10.6061/clinics/2019/e837.
  • Thariya P, Yospaiboon Y, Sinawat S, Sanguansak T, Bhoomibunchoo C, Laovirojjanakul W. Blood culture bottles are superior to conventional media for vitreous culture. Clin Exp Ophthalmol. 2016;44(6):488–491. doi:10.1111/ceo.12707.
  • Tan HS, Ghyczy-Carlborg EAE, Spanjaard L, De Smet MD. The additional value of blood culture bottles in the diagnosis of endophthalmitis. Eye. 2011;25(8):1069–1073. doi:10.1038/eye.2011.142.
  • Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1–e50. doi:10.1093/cid/civ933.
  • Serban D, Popa Cherecheanu A, Dascalu AM, et al. Hypervirulent Klebsiella pneumoniae endogenous endophthalmitis—a global emerging disease. Life. 2021;11(7):676. doi:10.3390/life11070676.
  • Hussain I, Ishrat S, Dcw H, et al. Endogenous endophthalmitis in Klebsiella pneumoniae pyogenic liver abscess: systematic review and meta-analysis. Int J Infect Dis. 2020;101:259–268. doi:10.1167/iovs.18-23783.
  • Bhikoo R, Ingram PR, Cunningham W, Gounder P, Host B, Chen FK. Risk of Klebsiella pneumoniae endogenous endophthalmitis during bacteremia: implications for screening. Infect Chemother. 2021;53(2):381. doi:10.3947/ic.2021.0023.
  • Grzybowski A, Turczynowska M, Schwartz SG, Relhan N, Flynn HW. The role of systemic antimicrobials in the treatment of endophthalmitis: a review and an international perspective. Ophthalmol Ther. 2020;9(3):485–498. doi:10.1007/s40123-020-00270-w.
  • Patterson TF, Thompson IIIGR, Denning DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63(4):e1–e60. doi:10.1093/cid/ciw326.
  • Brockhaus L, Goldblum D, Eggenschwiler L, Zimmerli S, Marzolini C. Revisiting systemic treatment of bacterial endophthalmitis: a review of intravitreal penetration of systemic antibiotics. Clin Microbiol Infect. 2019;25(11):1364–1369. doi:10.1016/j.cmi.2019.01.017.
  • Corredores J, Hemo I, Jaouni T, et al. Endogenous fungal endophthalmitis: risk factors, clinical course, and visual outcome in 13 patients. Int J Ophthalmol. 2021;14(1):97. doi:10.18240/ijo.2021.01.14.
  • Spelta S, Di Zazzo A, Antonini M, Bonini S, Coassin M. Does endogenous endophthalmitis need a more aggressive treatment? Ocul Immunol Inflamm. 2021;29(5):937–943. doi:10.1080/09273948.2019.1705497.
  • Spadea L, Giannico MI. Diagnostic and management strategies of Aspergillus endophthalmitis: current insights. Clin Ophthalmol (Auckland, NZ). 2019;13:2573. doi:10.2147/OPTH.S219264.
  • Majji AB, Jalali S, Das T, Gopinathan U. Role of intravitreal dexamethasone in exogenous fungal endophthalmitis. Eye. 1999;13(5):660–665. doi:10.1038/eye.1999.179.
  • Riddell IVJ, Comer GM, Kauffman CA. Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents. Clin Infect Dis. 2011;52(5):648–653. doi:10.1093/cid/ciq204.
  • Weng TH, Chang HC, Chung CH, et al. Epidemiology and mortality-related prognostic factors in endophthalmitis. Invest Ophthalmol Vis Sci. 2018;59(6):2487–2494.
  • Shenoy SB, Thotakura M, Kamath Y, Bekur R. Endogenous endophthalmitis in patients with MRSA septicemia: a case series and review of literature. Ocul Immunol Inflamm. 2016;24(5):515–520. doi:10.3109/09273948.2015.1020173.
  • Lee S, Um T, Joe SG, et al. Changes in the clinical features and prognostic factors of endogenous endophthalmitis: fifteen years of clinical experience in Korea. Retina. 2012;32(5):977–984. doi:10.1097/IAE.0b013e318228e312.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.